BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.

Comments (0)

No login
gif